Nina Vanessa Kraguljac1, Thomas Anthony2, Frank Michael Skidmore3, Jon Marstrander2, Charity Johanna Morgan4, Meredith Amanda Reid5, David Matthew White6, Ripu Daman Jindal7, Nicholas Harry Melas Skefos6, Adrienne Carol Lahti6. 1. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: nkraguljac@uabmc.edu. 2. Department of Electrical and Computer Engineering/IT Research Computing, University of Alabama at Birmingham, Birmingham, Alabama. 3. Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama. 4. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama. 5. MRI Research Center, Department of Electrical and Computer Engineering, Auburn University, Auburn, Alabama. 6. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama. 7. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Neurology, Birmingham VA Medical Center, Birmingham, Alabama.
Abstract
BACKGROUND: Schizophrenia is associated with progressive white matter changes, but it is unclear whether antipsychotic medications contribute to these. Our objective was to characterize effects of short-term treatment with risperidone on white matter diffusion indices. METHODS: We recruited 42 patients with schizophrenia (30 never treated and 12 currently untreated) and 42 matched healthy control subjects in this prospective case-control neuroimaging study. Patients received a 6-week trial of risperidone. Using diffusion tensor imaging, we assessed microstructural (fractional anisotropy, mean diffusivity, and radial diffusivity) and macrostructural (radial fiber trophy) white matter integrity deficits in unmedicated patients compared with control subjects and change in white matter integrity in patients before and after antipsychotic treatment (mean risperidone dose at end point was 3.73 ± 1.72 mg). RESULTS: At baseline, fractional anisotropy was decreased in the left medial temporal white matter (cluster extent: 123 voxels; Montreal Neurological Institute peak coordinates: x = -51, y = -44, z = -7; α < .05), and mean diffusivity was increased in the fusiform/lingual gyrus white matter extending to the hippocampal part of the cingulum (cluster extent: 185 voxels; peak coordinates: x = -27, y = -49, z = 2; α < .04) in patients compared with control subjects. Radial diffusivity and macrostructure were not abnormal. None of the diffusion indices showed a significant change after 6 weeks of treatment with both voxelwise and whole-brain white matter analyses. CONCLUSIONS: We demonstrate microstructural white matter integrity abnormalities in the absence of macrostructural impairment in unmedicated patients with primarily early-stage schizophrenia. In our data, we found no significant white matter changes after short-term treatment with risperidone.
BACKGROUND: Schizophrenia is associated with progressive white matter changes, but it is unclear whether antipsychotic medications contribute to these. Our objective was to characterize effects of short-term treatment with risperidone on white matter diffusion indices. METHODS: We recruited 42 patients with schizophrenia (30 never treated and 12 currently untreated) and 42 matched healthy control subjects in this prospective case-control neuroimaging study. Patients received a 6-week trial of risperidone. Using diffusion tensor imaging, we assessed microstructural (fractional anisotropy, mean diffusivity, and radial diffusivity) and macrostructural (radial fiber trophy) white matter integrity deficits in unmedicated patients compared with control subjects and change in white matter integrity in patients before and after antipsychotic treatment (mean risperidone dose at end point was 3.73 ± 1.72 mg). RESULTS: At baseline, fractional anisotropy was decreased in the left medial temporal white matter (cluster extent: 123 voxels; Montreal Neurological Institute peak coordinates: x = -51, y = -44, z = -7; α < .05), and mean diffusivity was increased in the fusiform/lingual gyrus white matter extending to the hippocampal part of the cingulum (cluster extent: 185 voxels; peak coordinates: x = -27, y = -49, z = 2; α < .04) in patients compared with control subjects. Radial diffusivity and macrostructure were not abnormal. None of the diffusion indices showed a significant change after 6 weeks of treatment with both voxelwise and whole-brain white matter analyses. CONCLUSIONS: We demonstrate microstructural white matter integrity abnormalities in the absence of macrostructural impairment in unmedicated patients with primarily early-stage schizophrenia. In our data, we found no significant white matter changes after short-term treatment with risperidone.
Authors: Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero Journal: Neuropsychopharmacology Date: 2016-06-08 Impact factor: 7.853
Authors: S G Fillman; N Cloonan; V S Catts; L C Miller; J Wong; T McCrossin; M Cairns; C S Weickert Journal: Mol Psychiatry Date: 2012-08-07 Impact factor: 15.992
Authors: Kristi A Clark; Keith H Nuechterlein; Robert F Asarnow; Liberty S Hamilton; Owen R Phillips; Nathan S Hageman; Roger P Woods; Jeffry R Alger; Arthur W Toga; Katherine L Narr Journal: J Psychiatr Res Date: 2011-02-08 Impact factor: 4.791
Authors: Q Wang; C Cheung; W Deng; M Li; C Huang; X Ma; Y Wang; L Jiang; P C Sham; D A Collier; Q Gong; S E Chua; G M McAlonan; T Li Journal: Psychol Med Date: 2013-02-27 Impact factor: 7.723
Authors: Philip R Szeszko; Delbert G Robinson; Toshikazu Ikuta; Bart D Peters; Juan A Gallego; John Kane; Anil K Malhotra Journal: Neuropsychopharmacology Date: 2013-10-16 Impact factor: 7.853
Authors: S Kelly; N Jahanshad; A Zalesky; P Kochunov; I Agartz; C Alloza; O A Andreassen; C Arango; N Banaj; S Bouix; C A Bousman; R M Brouwer; J Bruggemann; J Bustillo; W Cahn; V Calhoun; D Cannon; V Carr; S Catts; J Chen; J-X Chen; X Chen; C Chiapponi; Kl K Cho; V Ciullo; A S Corvin; B Crespo-Facorro; V Cropley; P De Rossi; C M Diaz-Caneja; E W Dickie; S Ehrlich; F-M Fan; J Faskowitz; H Fatouros-Bergman; L Flyckt; J M Ford; J-P Fouche; M Fukunaga; M Gill; D C Glahn; R Gollub; E D Goudzwaard; H Guo; R E Gur; R C Gur; T P Gurholt; R Hashimoto; S N Hatton; F A Henskens; D P Hibar; I B Hickie; L E Hong; J Horacek; F M Howells; H E Hulshoff Pol; C L Hyde; D Isaev; A Jablensky; P R Jansen; J Janssen; E G Jönsson; L A Jung; R S Kahn; Z Kikinis; K Liu; P Klauser; C Knöchel; M Kubicki; J Lagopoulos; C Langen; S Lawrie; R K Lenroot; K O Lim; C Lopez-Jaramillo; A Lyall; V Magnotta; R C W Mandl; D H Mathalon; R W McCarley; S McCarthy-Jones; C McDonald; S McEwen; A McIntosh; T Melicher; R I Mesholam-Gately; P T Michie; B Mowry; B A Mueller; D T Newell; P O'Donnell; V Oertel-Knöchel; L Oestreich; S A Paciga; C Pantelis; O Pasternak; G Pearlson; G R Pellicano; A Pereira; J Pineda Zapata; F Piras; S G Potkin; A Preda; P E Rasser; D R Roalf; R Roiz; A Roos; D Rotenberg; T D Satterthwaite; P Savadjiev; U Schall; R J Scott; M L Seal; L J Seidman; C Shannon Weickert; C D Whelan; M E Shenton; J S Kwon; G Spalletta; F Spaniel; E Sprooten; M Stäblein; D J Stein; S Sundram; Y Tan; S Tan; S Tang; H S Temmingh; L T Westlye; S Tønnesen; D Tordesillas-Gutierrez; N T Doan; J Vaidya; N E M van Haren; C D Vargas; D Vecchio; D Velakoulis; A Voineskos; J Q Voyvodic; Z Wang; P Wan; D Wei; T W Weickert; H Whalley; T White; T J Whitford; J D Wojcik; H Xiang; Z Xie; H Yamamori; F Yang; N Yao; G Zhang; J Zhao; T G M van Erp; J Turner; P M Thompson; G Donohoe Journal: Mol Psychiatry Date: 2017-10-17 Impact factor: 15.992
Authors: Nina Vanessa Kraguljac; Thomas Anthony; William Stonewall Monroe; Frank Michael Skidmore; Charity Johanna Morgan; David Matthew White; Neel Patel; Adrienne Carol Lahti Journal: Neuropsychopharmacology Date: 2019-06-01 Impact factor: 7.853
Authors: Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi Journal: Mol Psychiatry Date: 2021-01-22 Impact factor: 13.437
Authors: David J Williamson; Keith H Nuechterlein; Todd Tishler; Joseph Ventura; Benjamin M Ellingson; Ibrahim Turkoz; Richard S E Keefe; Larry Alphs Journal: Schizophr Res Cogn Date: 2022-09-05
Authors: Amanda E Lyall; Felix L Nägele; Ofer Pasternak; Juan A Gallego; Anil K Malhotra; Robert K McNamara; Marek Kubicki; Bart D Peters; Delbert G Robinson; Philip R Szeszko Journal: Psychiatry Res Neuroimaging Date: 2020-11-04 Impact factor: 2.376
Authors: Petra Verena Viher; Katharina Stegmayer; Tobias Bracht; Andrea Federspiel; Stephan Bohlhalter; Werner Strik; Roland Wiest; Sebastian Walther Journal: Schizophr Bull Date: 2022-01-21 Impact factor: 9.306